Cohen Lawrence B boosted its position in Danaher Corporation (NYSE:DHR) by 10.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,490 shares of the conglomerate’s stock after buying an additional 320 shares during the period. Cohen Lawrence B’s holdings in Danaher Corporation were worth $295,000 at the end of the most recent quarter.
Other large investors have also recently made changes to their positions in the company. Peddock Capital Advisors LLC raised its stake in shares of Danaher Corporation by 17.4% in the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock worth $105,000 after buying an additional 181 shares during the period. Proficio Capital Partners LLC boosted its stake in Danaher Corporation by 92.3% in the first quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock valued at $105,000 after buying an additional 598 shares in the last quarter. ClariVest Asset Management LLC bought a new stake in Danaher Corporation during the first quarter valued at approximately $157,000. Motco boosted its stake in Danaher Corporation by 26.7% in the first quarter. Motco now owns 1,848 shares of the conglomerate’s stock valued at $158,000 after buying an additional 390 shares in the last quarter. Finally, Baystate Wealth Management LLC boosted its stake in Danaher Corporation by 3.3% in the first quarter. Baystate Wealth Management LLC now owns 1,900 shares of the conglomerate’s stock valued at $163,000 after buying an additional 60 shares in the last quarter. 76.56% of the stock is currently owned by institutional investors and hedge funds.
Shares of Danaher Corporation (DHR) traded up 0.82% on Friday, reaching $79.94. 1,225,874 shares of the company’s stock traded hands. Danaher Corporation has a 12-month low of $75.71 and a 12-month high of $88.01. The company has a market cap of $55.53 billion, a PE ratio of 25.52 and a beta of 1.03. The stock has a 50-day moving average price of $83.07 and a 200-day moving average price of $84.21.
Danaher Corporation (NYSE:DHR) last announced its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.97 by $0.02. The firm had revenue of $4.51 billion during the quarter, compared to analyst estimates of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. Danaher Corporation’s revenue was up 6.3% on a year-over-year basis. During the same period last year, the firm posted $0.90 EPS. Equities research analysts anticipate that Danaher Corporation will post $3.95 EPS for the current fiscal year.
Several equities research analysts have recently commented on the stock. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a $88.00 target price (down from $89.00) on shares of Danaher Corporation in a research report on Friday, April 21st. BidaskClub cut shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Tuesday, July 25th. Zacks Investment Research cut shares of Danaher Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, July 27th. Citigroup Inc. set a $96.00 price target on shares of Danaher Corporation and gave the company a “buy” rating in a research report on Friday, July 21st. Finally, Janney Montgomery Scott cut shares of Danaher Corporation from a “buy” rating to a “neutral” rating in a research report on Wednesday, June 7th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $91.76.
In related news, Director Linda P. Hefner sold 10,578 shares of the stock in a transaction that occurred on Friday, July 21st. The shares were sold at an average price of $83.03, for a total value of $878,291.34. Following the completion of the transaction, the director now directly owns 42,151 shares of the company’s stock, valued at approximately $3,499,797.53. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Angela S. Lalor sold 10,815 shares of the stock in a transaction that occurred on Tuesday, May 23rd. The shares were sold at an average price of $84.16, for a total transaction of $910,190.40. Following the completion of the transaction, the senior vice president now directly owns 39,020 shares of the company’s stock, valued at $3,283,923.20. The disclosure for this sale can be found here. Insiders sold a total of 38,623 shares of company stock valued at $3,206,426 over the last ninety days. 12.20% of the stock is currently owned by insiders.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
What are top analysts saying about Danaher Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Danaher Corporation and related companies.